Epstein Secrets

Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicameral Dems discuss pa

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicameral Dems discuss pa

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicameral Dems discuss pa

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying